| Gamma interferon release assays for detection of Mycobacterium tuberculosis infection M Pai, CM Denkinger, SV Kik, MX Rangaka, A Zwerling, O Oxlade, ... Clinical microbiology reviews 27 (1), 3-20, 2014 | 1027 | 2014 |
| WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update World Health Organization World Health Organization, 2022 | 990 | 2022 |
| Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries H Getahun, A Matteelli, I Abubakar, MA Aziz, A Baddeley, D Barreira, ... European Respiratory Journal 46 (6), 1563-1576, 2015 | 761 | 2015 |
| Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis MX Rangaka, KA Wilkinson, JR Glynn, D Ling, D Menzies, ... The Lancet infectious diseases 12 (1), 45-55, 2012 | 656 | 2012 |
| Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome G Meintjes, RJ Wilkinson, C Morroni, DJ Pepper, K Rebe, MX Rangaka, ... Aids 24 (15), 2381-2390, 2010 | 452 | 2010 |
| Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn, K Fielding, ... The Lancet 384 (9944), 682-690, 2014 | 324 | 2014 |
| The South African tuberculosis care cascade: estimated losses and methodological challenges P Naidoo, G Theron, MX Rangaka, VN Chihota, L Vaughan, ZO Brey, ... The Journal of infectious diseases 216 (suppl_7), S702-S713, 2017 | 293 | 2017 |
| Effect of HIV-1 infection on T-cell–based and skin test detection of tuberculosis infection MX Rangaka, KA Wilkinson, R Seldon, G Van Cutsem, GA Meintjes, ... American journal of respiratory and critical care medicine 175 (5), 514-520, 2007 | 280 | 2007 |
| Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa AR Martineau, S Nhamoyebonde, T Oni, MX Rangaka, S Marais, ... Proceedings of the National Academy of Sciences 108 (47), 19013-19017, 2011 | 268 | 2011 |
| Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection MX Rangaka, SC Cavalcante, BJ Marais, S Thim, NA Martinson, ... The Lancet 386 (10010), 2344-2353, 2015 | 247 | 2015 |
| Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa R Wood, H Liang, H Wu, K Middelkoop, T Oni, MX Rangaka, RJ Wilkinson, ... The international journal of tuberculosis and lung disease 14 (4), 406-412, 2010 | 220 | 2010 |
| Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series DJ Pepper, S Marais, G Maartens, K Rebe, C Morroni, MX Rangaka, T Oni, ... Clinical Infectious Diseases 48 (11), e96-e107, 2009 | 217 | 2009 |
| Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome R Tadokera, G Meintjes, KH Skolimowska, KA Wilkinson, K Matthews, ... European Respiratory Journal 37 (5), 1248-1259, 2011 | 183 | 2011 |
| Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis RK Gupta, CT Turner, C Venturini, H Esmail, MX Rangaka, A Copas, ... The Lancet Respiratory Medicine 8 (4), 395-406, 2020 | 180 | 2020 |
| Type 1 helper T cells and FoxP3-positive T cells in HIV–tuberculosis-associated immune reconstitution inflammatory syndrome G Meintjes, KA Wilkinson, MX Rangaka, K Skolimowska, K Van Veen, ... American journal of respiratory and critical care medicine 178 (10), 1083-1089, 2008 | 180 | 2008 |
| A user-centred design framework for mHealth J Farao, B Malila, N Conrad, T Mutsvangwa, MX Rangaka, TS Douglas PloS one 15 (8), e0237910, 2020 | 173 | 2020 |
| Tracking COVID-19 using online search V Lampos, MS Majumder, E Yom-Tov, M Edelstein, S Moura, Y Hamada, ... NPJ digital medicine 4 (1), 17, 2021 | 168 | 2021 |
| Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance G Meintjes, MX Rangaka, G Maartens, K Rebe, C Morroni, DJ Pepper, ... Clinical infectious diseases 48 (5), 667-676, 2009 | 150 | 2009 |
| Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans MX Rangaka, L Diwakar, R Seldon, G Van Cutsem, GA Meintjes, ... Clinical infectious diseases 44 (12), 1639-1646, 2007 | 108 | 2007 |
| Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome G Meintjes, KH Skolimowska, KA Wilkinson, K Matthews, R Tadokera, ... American journal of respiratory and critical care medicine 186 (4), 369-377, 2012 | 87 | 2012 |
